Equity Medical, LLC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)3 trials
• Hidradenitis suppurativa3 trials
• Obesity1 trial

Phase

• Phase 23 trials
• Phase 11 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting3 trials
• Recruiting3 trials

Lead sponsor

• Bluefin Biomedicine, Inc.2 trials
• Bambusa Therapeutics1 trial
• Navigator Medicines, Inc.1 trial
• Organon and Co1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity

  NCT07830329· Phase 2· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

  NCT07384975· Phase 2· Navigator Medicines, Inc.· Source

  Contact: Associate Director, Clinical Operations

• Active, not recruiting

  A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

  NCT07265479· Phase 3· Organon and Co· Source

• Active, not recruiting

  A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

  NCT07287644· Phase 2/3· Bluefin Biomedicine, Inc.· Source

• Active, not recruiting

  A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

  NCT07105488· Phase 2· Bluefin Biomedicine, Inc.· Source

• Recruiting

  A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

  NCT06808477· Phase 1· Bambusa Therapeutics· Source

  Contact: Lisa Li

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Obesity1 recruiting